RecruitingPhase 1

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

United States60 participantsStarted 2025-02-27

Plain-language summary

A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients assigned female at birth, * booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates. Exclusion Criteria: * Allergy to ketorolac or non-steroidal anti-inflammatory medications * Allergy to lidocaine * Presence of thrombocytopenia * Contraindications to lidocaine * History of gastritis or gastric ulcer * Acute renal failure or chronic renal disease * Chronic liver disease * History of bleeding diathesis * Long term narcotic use

What they're measuring

Pain visual analogue scale (VAS)

Timeframe: during procedure (cervical dilation)

Trial details

NCT IDNCT06653400

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-01

Contact for this trial

Kathleen E Ackert, DO

212-241-4500 kathleen.ackert@mssm.edu

View on ClinicalTrials.gov More Abnormal Uterine Bleeding trials